Flumazenil Injection, Solution
Product Images NDC 84549-784

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Flumazenil (NDC 84549-784). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Propharma Distribution, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (84549 784 10)

This text provides information about Flumazenil IV Solution, a medication that is administered intravenously. It contains 0.1mg per mL and comes in a 5mL vial. The storage conditions are specified, with instructions to avoid aerosol generation during preparation. The text also includes details such as the item number, lot numbers, expiration date, and manufacturer information from Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Structural Formula (Flumazenil 1)

FDA Label Image

Chart 1 (Flumazenil 2)

This text provides information on the magnitude and duration of the reversal of sedation when administering different doses of Flumazenil. The Flumazenil doses evaluated were 0.2 mg, 0.6 mg, and 1 mg, with corresponding blood levels in ng/mL. The impact of Flumazenil injections on sedation caused by midazolam infusion at a specific rate in healthy volunteers is also discussed. The data appears to show how quickly sedation can be reversed by Flumazenil at varying doses.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.